HOPE4MCI Trial: First Trial Targeting Reduction of Hippocampal Overactivity to Treat Mild Cognitive Impairment due to Alzheimer’s Disease with AGB101

Presentation at Alzheimer’s Association International Conference (AAIC) Read more